Promentis Pharmaceuticals focuses on developing antipsychotic drugs to treat schizophrenia.
Industries BiotechnologyMedicalPharmaceuticalHeadquarters Regions Great Lakes, Midwestern US Founded Date 2006 Founders David A. Baker, John Mantsch Operating Status Active Last Funding Type Venture - Series Unknown Legal Name Promentis Pharmaceuticals Inc.
Company Type For Profit
Contact Email contact@promentispharma.com Phone Number (414)238-2992
Promentis Pharmaceuticals discovers, develops, and markets new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia.
Promentis Pharmaceuticals was founded in 2006 and is based in Milwaukee, Wisconsin.